These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Electrophysiological evaluation and visual outcome in patients with central retinal vein occlusion, primary open-angle glaucoma and neovascular glaucoma. Wittström E; Ponjavic V; Lövestam-Adrian M; Larsson J; Andréasson S Acta Ophthalmol; 2010 Feb; 88(1):86-90. PubMed ID: 19432876 [TBL] [Abstract][Full Text] [Related]
5. The mechanism and therapeutic strategies for neovascular glaucoma secondary to diabetic retinopathy. Tang Y; Shi Y; Fan Z Front Endocrinol (Lausanne); 2023; 14():1102361. PubMed ID: 36755912 [TBL] [Abstract][Full Text] [Related]
6. A prospective, randomised, placebo-controlled, double-masked, three-armed, multicentre phase II/III trial for the Study of a Topical Treatment of Ischaemic Central Retinal Vein Occlusion to Prevent Neovascular Glaucoma - the STRONG study: study protocol for a randomised controlled trial. Lorenz K; Scheller Y; Bell K; Grus F; Ponto KA; Bock F; Cursiefen C; Flach J; Gehring M; Peto T; Silva R; Tal Y; Pfeiffer N Trials; 2017 Mar; 18(1):128. PubMed ID: 28302155 [TBL] [Abstract][Full Text] [Related]
7. Predictors of Neovascular Glaucoma in Central Retinal Vein Occlusion. Rong AJ; Swaminathan SS; Vanner EA; Parrish RK Am J Ophthalmol; 2019 Aug; 204():62-69. PubMed ID: 30862502 [TBL] [Abstract][Full Text] [Related]
8. CLINICAL IMPACT IN THE MANAGEMENT OF NEOVASCULAR GLAUCOMA. Ajvazi H; Lutaj P Rom J Ophthalmol; 2015; 59(3):154-8. PubMed ID: 26978883 [TBL] [Abstract][Full Text] [Related]
9. NEOVASCULAR SECONDARY GLAUCOMA, ETIOLOGY AND PATHOGENESIS. Barac IR; Pop MD; Gheorghe AI; Taban C Rom J Ophthalmol; 2015; 59(1):24-8. PubMed ID: 27373111 [TBL] [Abstract][Full Text] [Related]
10. [Neovascular glaucoma--etipathogeny and diagnosis]. Călugăru D; Călugăru M Oftalmologia; 2012; 56(2):3-14. PubMed ID: 23424756 [TBL] [Abstract][Full Text] [Related]
11. [Current approaches in neovascular glaucoma]. Zhang XL Zhonghua Yan Ke Za Zhi; 2012 Jun; 48(6):488-91. PubMed ID: 22943801 [TBL] [Abstract][Full Text] [Related]
12. The pathological association between the anterior eye segment and the retina in a murine model of neovascular glaucoma. Nishinaka A; Tanaka M; Aoshima K; Kuriyama A; Sasaki T; Otsu W; Yasuda H; Nakamura S; Shimazawa M; Hara H FASEB J; 2022 Jun; 36(6):e22323. PubMed ID: 35485981 [TBL] [Abstract][Full Text] [Related]
13. [Treatment of neovascular glaucoma]. Călugăru D; Călugăru M Oftalmologia; 2012; 56(3):20-39. PubMed ID: 23713336 [TBL] [Abstract][Full Text] [Related]
15. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases. Wakabayashi T; Oshima Y; Sakaguchi H; Ikuno Y; Miki A; Gomi F; Otori Y; Kamei M; Kusaka S; Tano Y Ophthalmology; 2008 Sep; 115(9):1571-80, 1580.e1-3. PubMed ID: 18440643 [TBL] [Abstract][Full Text] [Related]
16. Neovascular glaucoma in a Nigerian African population. Ashaye AO; Adeoti CO East Afr Med J; 2006 Oct; 83(10):559-64. PubMed ID: 17310682 [TBL] [Abstract][Full Text] [Related]
17. [The relevance of diabetes for patients with glaucoma]. Klemm M; Gesser C Klin Monbl Augenheilkd; 2014 Feb; 231(2):116-20. PubMed ID: 24532397 [TBL] [Abstract][Full Text] [Related]
18. Role of Platelet Parameters on Neovascular Glaucoma: A Retrospective Case-Control Study in China. Li S; Cao W; Sun X PLoS One; 2016; 11(12):e0166893. PubMed ID: 27907042 [TBL] [Abstract][Full Text] [Related]